WEDNESDAY, Jan. 15, 2025 (HealthDay News) — The female survival advantage seen in melanoma is mainly a result of an indirect effect of sex mediated by clinicopathological features, according to a study published online Jan. 12 in JNCI Cancer Spectrum.
Of Interest
Penn Medicine scientists develop tiny anticancer weapon
PHILADELPHIA – A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
FDA Clears Investigational New Drug Application for R-5780 in Solid Tumors
The RISE R-5780-01 trial will evaluate the safety and tolerability of R-5780 in patients with melanoma, basal cell carcinoma, or squamous cell carcinoma.
Diabetes Drug Metformin May Have Another Use: Protecting Against Skin Cancer
However, metformin did not protect Black patients against squamous cell carcinoma specifically.